Tandem Nano
PrivateLast Round
Pre Seed
Apr 1, 2019
Company Overview
Tandem Nano is a biotechnology company that develops a solid drug nanoparticle technology platform designed to transform the delivery of active compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tandem Nano Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Tandem Nano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 1, 2019 |
Tandem Nano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Liverpool | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2019
Led by University of Liverpool Enterprise Fund.
Tandem Nano Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tandem Nano's valuation, stock price, and market status.